Goldman Sachs’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $229M | Sell |
710,734
-5,450
| -0.8% | -$1.69M | 0.03% | 620 |
|
|
2025
Q4 | $211M | Buy |
716,184
+123,163
| +21% | +$22.9M | 0.03% | 617 |
|
|
2025
Q3 | $31.4M | Buy |
593,021
+367,029
| +162% | +$17.8M | ﹤0.01% | 1825 |
|
|
2025
Q2 | $9.5M | Buy |
225,992
+48,728
| +27% | +$1.86M | ﹤0.01% | 2803 |
|
|
2025
Q1 | $6.71M | Sell |
177,264
-102,131
| -37% | -$6.38M | ﹤0.01% | 3066 |
|
|
2024
Q4 | $21.5M | Sell |
279,395
-225
| -0.1% | -$16.3K | ﹤0.01% | 2059 |
|
|
2024
Q3 | $16.1M | Buy |
279,620
+148,623
| +113% | +$8.03M | ﹤0.01% | 2257 |
|
|
2024
Q2 | $5.42M | Buy |
130,997
+32,362
| +33% | +$1.53M | ﹤0.01% | 3075 |
|
|
2024
Q1 | $6.02M | Buy |
+98,635
| New | +$4.43M | ﹤0.01% | 2926 |
|
|
2023
Q4 | – | Sell |
-6,174
| Closed | -$158K | – | 5791 |
|
|
2023
Q3 | $158K | Sell |
6,174
-4,061
| -40% | -$76.8K | ﹤0.01% | 5099 |
|
|
2023
Q2 | $177K | Sell |
10,235
-40,477
| -80% | -$620K | ﹤0.01% | 5224 |
|
|
2023
Q1 | $615K | Buy |
50,712
+2,749
| +6% | +$116K | ﹤0.01% | 4714 |
|
|
2022
Q4 | $1.71M | Sell |
47,963
-26,877
| -36% | -$838K | ﹤0.01% | 4057 |
|
|
2022
Q3 | $2.55M | Buy |
74,840
+35,127
| +88% | +$1.75M | ﹤0.01% | 3763 |
|
|
2022
Q2 | $1.46M | Buy |
39,713
+30,410
| +327% | +$3.25M | ﹤0.01% | 4317 |
|
|
2022
Q1 | $1.43M | Buy |
9,303
+4,244
| +84% | +$872K | ﹤0.01% | 4541 |
|
|
2021
Q4 | $1.5M | Sell |
5,059
-2,200
| -30% | -$645K | ﹤0.01% | 4502 |
|
|
2021
Q3 | $2.01M | Buy |
7,259
+1,500
| +26% | +$407K | ﹤0.01% | 4191 |
|
|
2021
Q2 | $1.58M | Sell |
5,759
-886
| -13% | -$317K | ﹤0.01% | 4408 |
|
|
2021
Q1 | $3.27M | Buy |
6,645
+2,263
| +52% | +$1.61M | ﹤0.01% | 3520 |
|
|
2020
Q4 | $3.62M | Buy |
+4,382
| New | +$2.56M | ﹤0.01% | 3261 |
|
Other funds holding PRAX
OAG
PA
BBA
VCM
DM
DCM
CAM